Compounds > kynostatin 272
Page last updated: 2024-08-24

kynostatin 272 and je 2147

kynostatin 272 has been researched along with je 2147 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukazawa, T; Hayashi, H; Kato, R; Kiso, Y; Mimoto, T; Misawa, S; Nojima, S; Sato, H; Shintani, M; Takaku, H; Terashima, K; Ueno, T1
Blum, LE; Clemente, JC; Dunn, BM; Goodenow, MM; Hemrajani, R1
Adachi, M; Hayashi, Y; Hidaka, K; Kameoka, M; Kempf, DJ; Kimura, T; Kiso, Y; Kuroki, R; McDaniel, KF; Nguyen, JT; Sankaranarayanan, R; Wang, J1

Other Studies

3 other study(ies) available for kynostatin 272 and je 2147

ArticleYear
Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine.
    Journal of medicinal chemistry, 1999, May-20, Volume: 42, Issue:10

    Topics: Administration, Oral; Animals; Biological Availability; Cell Line; Dipeptides; Dogs; Drug Evaluation, Preclinical; HIV Protease Inhibitors; HIV-1; Inhibitory Concentration 50; Injections, Intravenous; Oligopeptides; Phenylbutyrates; Rats; Structure-Activity Relationship; Thiazoles; Thiazolidines

1999
Secondary mutations M36I and A71V in the human immunodeficiency virus type 1 protease can provide an advantage for the emergence of the primary mutation D30N.
    Biochemistry, 2003, Dec-30, Volume: 42, Issue:51

    Topics: Alanine; Anti-HIV Agents; Asparagine; Aspartic Acid; Binding Sites; Drug Resistance, Viral; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoleucine; Kinetics; Methionine; Mutagenesis, Site-Directed; Nelfinavir; Ritonavir; Valine

2003
Identification of Highly Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors against Lopinavir and Darunavir Resistant Viruses from Allophenylnorstatine-Based Peptidomimetics with P2 Tetrahydrofuranylglycine.
    Journal of medicinal chemistry, 2018, 06-28, Volume: 61, Issue:12

    Topics: Crystallography, X-Ray; Darunavir; Drug Resistance, Viral; Glycine; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Peptidomimetics; Phenylbutyrates; Serum; Structure-Activity Relationship

2018